Articles tagged "African-American"

2019 American Transplant Congress
The Impact of Race on Metabolic, Graft and Patient Outcomes after Pancreatic Transplantation
V. S. Rohan, S. N. Nadig, J. Mcgillicuddy, V. Rao, D. Dubay, K. Soliman, P. Baliga, D. Taber
Transplant Surgery, Medical University of South Carolina, Charleston, SC
*Purpose: Health disparities in African-Americans (AAs) are well-documented in kidney transplantation. There is a paucity of data regarding effect race in pancreas transplant (PTX) outcomes.*Methods:…
2019 American Transplant Congress
Race-Sex Effects on Immune Response Potential during Tacrolimus Minimization Therapy in Stable Renal Allograft Recipients
K. Tornatore¹, K. Attwood², R. Venuto³, H. Minderman⁴
¹University at Buffalo; School of Pharmacy, Buffalo, NY, ²Biostatistics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, ³University at Buffalo; School of Medicine: Nephrology, Buffalo, NY, ⁴Flow & Image Cytometry, Roswell Park Comprehensive Cancer Center, Buffalo, NY
*Purpose: African American renal transplant recipients (RTR) exhibit more immunoreactivity to allografts which may contribute to chronic rejection. This study investigated race-sex influences on ex…
2019 American Transplant Congress
Lack of Linguistically and Culturally Tailored Initiatives in Kidney Transplant Programs in the United States
S. Carbunaru¹, A. Ortiz², C. Ortiz³, J. Ortiz³, J. Locke⁴, J. Caicedo¹
¹Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, ²University of California, Los Angeles, Los Angeles, CA, ³Department of Surgery, University of Toledo College of Medicine & Life Sciences, Toledo, OH, ⁴University of Alabama at Birmingham, Birmingham, AL
*Purpose: Although minorities are the majorities in the kidney transplant waiting list, it is unknown if kidney transplant programs in United States have implemented linguistically…
2019 American Transplant Congress
Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations within Ninety Days of Renal Transplant
S. Patel, K. Khalil, A. Lichvar, E. Benedetti, P. West-Thielke
University of Illinois Hospital and Health Sciences System, Chicago, IL
*Purpose: Optimizing tacrolimus (TAC) time within therapeutic range (TTR) has been shown to improve outcomes post-transplant. To date, there are no studies assessing differences in…
2019 American Transplant Congress
Excellent Outcome in African-American (AA), Type 1 and Type 2 Diabetic Recipients after Simultaneous Pancreas and Kidney Transplantation (SPK)
A. Gruessner, S. Saggi, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: African-American recipients (AA) are considered a high risk group for organ transplantation. As outcomes after pancreas transplantation have significantly improved, the number of transplants…
2019 American Transplant Congress
Clinical Impact of Race and Timing of Acute Rejection on Recipients of Kidney Transplant on Early Steroid Withdrawal Protocol
O. Adebiyi, S. Yaqub, W. Goggins, D. Mishler, T. Taber, A. Sharfuddin
Indiana University, Indianapolis, IN
*Purpose: There has been conflicting reports on the impacts of the timing of acute rejection (AR) (early vs late) on the overall outcome of a…
2019 American Transplant Congress
Dosing Requirements Of Astagraf Xl In African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus (aaaktrs)
J. N. Fleming, M. A. Posadas-Salas, D. J. Taber
Medical University of South Carolina, Charleston, SC
*Purpose: Pharmacokinetics from clinical studies demonstrated similar drug exposure (AUC) and correlation between trough (C0) and AUC between tacrolimus IR and Astagraf XL, which led…
2019 American Transplant Congress
Evaluation of Envarsus XR in African American Kidney Transplant Recipients
L. R. Lineberger¹, E. Hollinger², N. Kenyon¹, M. Brokohf¹, N. Alvey¹
¹Pharmacy, Rush University Medical Center, Chicago, IL, ²Rush University Medical Center, Chicago, IL
*Purpose: This study is being conducted to evaluate the clinical impact of the utilization of tacrolimus LCP (TAC-LCP) compared to tacrolimus immediate release (TAC-IR) in…
2019 American Transplant Congress
Patterns Of Anti-retroviral Use Among U.s. Liver Transplant Candidates With Hiv
A. A. Shaffer¹, A. G. Thomas², D. L. Segev³
¹Johns Hopkins University, Baltimore, MD, ²Epidemiology, University of North Carolina, Chapel Hill, NC, ³Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD
*Purpose: There is a high burden of liver disease among HIV-infected (HIV+) individuals, and the class of antiretroviral therapy (ART) used for their treatment may…
2019 American Transplant Congress
Studying the Association of Melanocortin Receptor-4 Gene Polymorphism and Renal Transplant Rejection
F. Yilmaz¹, R. Abdi¹, B. J. Keating², V. R. Mas³
¹Renal Division, Transplantation Research Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, ²Surgery, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA, ³Director Transplant Research Institute, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN
*Purpose: Accumulating experimental data highlight the importance of targeting the innate immune response to improve transplant outcomes. Inflammation is an unavoidable consequence of transplantation. The…